[KINGOLD JEWELRY ANNOUNCES APPOINTMENT OF ALICE IO WAI WU TO COMPANY’S BOARD OF DIRECTORS WUHAN CITY, China, May 9, 2016 - Kingold Jewelry, Inc. ("Kingold" or "the Company") (NASDAQ: KGJI), Ms. Wu has been providing accounting, consulting and advisory services to public and private companies since September 2011 through her company Wu & Company, Inc. Ms. Wu has also been] []
[Orient Paper, Inc. Announces Unaudited Preliminary Financial Results for First Quarter 2016 Company to Host Earnings Conference Call on Thursday, May 12, 2016, at 8:00 am ET Selected First Quarter 2016 Financial Results (Unaudited and Preliminary) For the Three Months Ended 2016 2015 % Change Revenue ($M) $ 27.9 $ 26.5 5.3 % Sales volume (tonnes) Regular Corrugating Medium Paper] []
[Orient Paper, Inc. Announces Unaudited Preliminary Financial Results for First Quarter 2016 Company to Host Earnings Conference Call on Thursday, May 12, 2016, at 8:00 am ET Selected First Quarter 2016 Financial Results (Unaudited and Preliminary) For the Three Months Ended 2016 2015 % Change Revenue ($M) $ 27.9 $ 26.5 5.3 % Sales volume (tonnes) Regular Corrugating Medium Paper] []
[Purchase Agreement for Land Use Right and Factory Facilities I. General 1. Party A owns factory facilities and land use rights for the facilities and land located at No. 2666 Kaifaqu Avenue, Rui’an Economic Development Zone, Rui’an City, Zhejiang Province PRC (“Development Zone Facility”). The building area and ancillary site area shall be the same as shown in the property] []
[Purchase Agreement for Land Use Right and Factory Facilities I. General 1. Party A owns factory facilities and land use rights for the facilities and land located at No. 2666 Kaifaqu Avenue, Rui’an Economic Development Zone, Rui’an City, Zhejiang Province PRC (“Development Zone Facility”). The building area and ancillary site area shall be the same as shown in the property] []
[IDI Announces 2016 First Quarter Financial and Operating Results Data and analytics company drives innovation, executing on growth in all segments and providing customers with market leading products Business Highlights -Consolidated revenue increased to $39.4 million for the first quarter 2016 from $1.3 million for the first quarter 2015 -Information Services and Performance Marketing segments contributed $11.0 million and $28.4] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): May 5, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 2.02 Results of Operations and Financial Condition. Top of the Form]
[IDI Announces 2016 First Quarter Financial and Operating Results Data and analytics company drives innovation, executing on growth in all segments and providing customers with market leading products Business Highlights -Consolidated revenue increased to $39.4 million for the first quarter 2016 from $1.3 million for the first quarter 2015 -Information Services and Performance Marketing segments contributed $11.0 million and $28.4] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): May 5, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 2.02 Results of Operations and Financial Condition. Top of the Form]
[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT April 29, 2016 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28- 8551-6696 ☐ ☐]
[CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT April 29, 2016 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28- 8551-6696 ☐ ☐]
